Fachliteratur Gastroenterologie: Funktionelle Beschwerden

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Magen-Darm » Funktionelle Beschwerden

17. August 2017

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Funktionelle Beschwerden

Schrift:

Seite 1 von 277


	Artikel 1 - 20 / 5532

	Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies. PLoS One Varjú P, Farkas N, Hegyi P, Garami A, Szabó I, Illés A, Solymár M, Vincze Á, Balaskó M, Pár G, Bajor J, Sz, Huszár O, Pécsi D, Czimmer J. PMID: 28806407 [PubMed - in process]
	Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study. Neurogastroenterol Motil Vork L, Weerts ZZRM, Mujagic Z, Kruimel JW, Hesselink MAM, Muris JWM, Keszthelyi D, Jonkers DMAE, Masclee AAM. PMID: 28804974 [PubMed - as supplied by publisher]
	Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights. Psychol Res Behav Manag Kinsinger SW. PMID: 28790872 [PubMed]
	Close association between intestinal microbiota and irritable bowel syndrome. Eur J Clin Microbiol Infect Dis Fan WT, Ding C, Xu NN, Zong S, Ma P, Gu B. PMID: 28785822 [PubMed - as supplied by publisher]
	HTR3A and HTR3E gene polymorphisms and diarrhea predominant irritable bowel syndrome risk: evidence from a meta-analysis. Oncotarget Guan T, Li T, Cai W, Huang D, Ouyang P, Wang Y, Chen H, Wu K, Ma X. PMID: 28778093 [PubMed - as supplied by publisher]
	Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome. Mol Cell Endocrinol Jacenik D, Cygankiewicz AI, Fichna J, Mokrowiecka A, Ma, Krajewska WM. PMID: 28774781 [PubMed - as supplied by publisher]
	Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome. BMC Gastroenterol El-Salhy M, Gilja OH. PMID: 28764761 [PubMed - in process]
	Effect of intragastric FODMAP infusion on upper gastrointestinal motility, gastrointestinal, and psychological symptoms in irritable bowel syndrome vs healthy controls. Neurogastroenterol Motil Masuy I, Van Oudenhove L, Tack J, Biesiekierski JR. PMID: 28762592 [PubMed - as supplied by publisher]
	Identification of serum proteome signature of irritable bowel syndrome: Potential utility of the tool for early diagnosis and patient's stratification. J Proteomics Tsigaridas A, Anagnostopoulos AK, Papadopoulou A, Ioakeim S, Vaiopoulou A, Papanikolaou IS, Viazis N, Karamanolis G, Mantzaris GJ, Tsangaris GT, Gazouli M. PMID: 28757466 [PubMed - as supplied by publisher]
	Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. World J Gastroenterol Harvie RM, Chisholm AW, Bisanz JE, Burton JP, Herbison P, Schultz K, Schultz M. PMID: 28740352 [PubMed - in process]
	Erratum to: the role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis. Parasitol Res Rostami A, Riahi SM, Haghighi A, Saber V, Armon B, Seyyedtabaei SJ. PMID: 28725935 [PubMed - in process]
	New psychological therapies for irritable bowel syndrome: mindfulness, acceptance and commitment therapy (ACT). Rev Esp Enferm Dig Sebastián Sánchez B, Gil Roales-Nieto J, Ferreira NB, Gil Luciano B, Sebastián Domingo JJ. PMID: 28724306 [PubMed - as supplied by publisher]
	Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome. Eur Rev Med Pharmacol Sci Spagnuolo R, Cosco C, Mancina RM, Ruggiero G, Garieri P, Cosco V, Doldo P. PMID: 28724171 [PubMed - in process]
	Effects of a Low FODMAP Diet and Specific Carbohydrate Diet on Symptoms and Nutritional Adequacy of Patients with Irritable Bowel Syndrome: Preliminary Results of a Single-blinded Randomized Trial. J Transl Int Med Vincenzi M, Del Ciondolo I, Pasquini E, Gennai K, Paolini B. PMID: 28721345 [PubMed]
	Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial. BMJ Open Kerckhove N, Scanzi J, Pereira B, Ardid D, Dapoigny M. PMID: 28720615 [PubMed - in process]
	Habitual diet and diet quality in Irritable Bowel Syndrome: AÂ case-control study. Neurogastroenterol Motil Tigchelaar EF, Mujagic Z, Zhernakova A, Hesselink MAM, Meijboom S, Perenboom CWM, Masclee AAM, Wijmenga C, Feskens EJM, Jonkers DMAE. PMID: 28714091 [PubMed - as supplied by publisher]
	A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome. Adv Nutr Lenhart A, Chey WD. PMID: 28710145 [PubMed - in process]
	Dietary Practices and Fodmaps in South Asia: Applicability of the Low Fodmap Diet to Patients with Irritable Bowel Syndrome. J Gastroenterol Hepatol Hewawasam SP, Iacovou M, Muir JG, Gibson PR. PMID: 28700090 [PubMed - as supplied by publisher]
	Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study. BMC Obes Aasbrenn M, Høgestøl I, Eribe I, Kristinsson J, Lydersen S, Mala T, Farup PG. PMID: 28680646 [PubMed]
	Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome-getting the facts right. Authors' reply. Aliment Pharmacol Ther Krogsgaard LR, Lyngesen M, Bytzer P. PMID: 28677288 [PubMed - in process]

Artikel 1 - 20 / 5532

Seite 1 von 277



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Werbung